The Oncology Ablation Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of oncology ablation has seen substantial growth in the recent past. The market, valued at $1.3 billion in 2024, is projected to climb to $1.46 billion in 2025, boasting a Compound Annual Growth Rate (CAGR) of 12.9%.
The oncology ablation market is projected to reach $2.35 billion in 2029, expanding at a compound annual growth rate (CAGR) of 12.6%.
Download Your Free Sample of the 2025 Oncology Ablation Market Report and Uncover Key Trends Now!The drivers in the oncology ablation market are:
• Increasing prevalence of cancer
• Preference for minimally invasive ablation techniques
• Increase in healthcare spending
• New approvals of ablation devices and technologies
The oncology ablation market covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation
2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer
The trends in the oncology ablation market are:
• The integration of artificial intelligence in oncology ablation techniques is a key emerging trend.
• There are advancements being made in medical imaging technologies that are set to shape the oncology ablation market.
• Robotic-assisted ablation is another significant trend influencing the future of the market.
• The introduction of advanced ablation devices with enhanced efficacy, safety, and user-friendliness is also revolutionizing the market.
The major players in the oncology ablation market are:
• Medtronic plc
• Siemens Healthineers AG
• Becton Dickinson and Company
• Koninklijke Philips N
North America was the largest region in the oncology ablation market in 2023